Targeting newly identified ERβ/TGF-β1/SMAD3 signals with the FDA-approved anti-estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma

Molecular Oncology
Wenbin SongShuyuan Yeh

Abstract

Renal cell carcinoma (RCC) has the third highest mortality rate among urological tumors, and 20-30% of RCC patients present with metastatic RCC at the time of diagnosis. Although recent studies have indicated that estrogen receptor β (ERβ) could play promoting roles in RCC progression, the detailed mechanisms remain to be clarified. In the present study, we found that expression of ERβ, but not ERα, increases with tumor stage and grade, and also observed that modification of ERβ signals using estrogens/anti-estrogens, shRNA knockdown of ERβ and overexpression of ERβ using ectopic cDNA affects RCC cell proliferation, migration and invasion. Mechanism analysis revealed that ERβ can promote RCC cell invasion via an increase in transforming growth factor β1 (TGF-β1)/SMAD3 signals, and interrupting TGF-β1/SMAD3 signals with a TGFβR1 inhibitor can reverse/block ERβ-increased RCC cell migration. Importantly, preclinical analyses using in vivo mouse models of RCC revealed that targeting of this newly identified ERβ/TGF-β1/SMAD3 pathway with either the FDA-approved anti-estrogen ICI182,780 (Faslodex) or a selective ERβ antagonist 4-[2-phenyl-5,7 bis(trifluoromethyl)pyrazolo[1,5-a]pyrimidin-3-yl]phenol can significantly reduce RCC tumor ...Continue Reading

References

Apr 1, 1979·The Journal of Clinical Endocrinology and Metabolism·G SchneiderN H Ertel
Jun 1, 1994·Journal of Molecular Endocrinology·C J NewtonG K Stalla
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R J Papac, M F Keohane
Jun 11, 1996·Proceedings of the National Academy of Sciences of the United States of America·G G KuiperJ A Gustafsson
Nov 7, 1999·Journal of Molecular Evolution·S T Kelley, V G Thackray
Nov 10, 2000·International Journal of Cancer. Journal International Du Cancer·K IwaoS Noguchi
Nov 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·Q ZhouR A Hess
Dec 13, 2002·Fertility and Sterility·Roya RozatiRubina Mujtaba
Jun 19, 2004·Current Opinion in Urology·Masaru Murai, Mototsugu Oya
Feb 12, 2005·Molecular Endocrinology·Ellis R Levin
Apr 5, 2007·Journal of the National Cancer Institute·Hiroshi MiyamotoChawnshang Chang
Sep 6, 2007·Journal of Cellular Biochemistry·Giuseppe Carruba
Mar 4, 2008·Cancer Treatment Reviews·Kiran GuptaClaudie Charbonneau
May 27, 2008·Steroids·Emily M FoxMargaret A Shupnik
Jul 19, 2011·Journal of Cellular and Molecular Medicine·Maritza E Mayorga, Marc S Penn
Oct 8, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Allison W WelshDavid L Rimm
Nov 25, 2011·Proceedings of the National Academy of Sciences of the United States of America·Selvaraj MuthusamyJan-Åke Gustafsson
Apr 3, 2012·Diagnostic and Interventional Imaging·E Compérat, P Camparo
Apr 14, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nabil F Saba, Stuart J Wong
Nov 15, 2017·Nucleic Acids Research·Suhas V VasaikarBing Zhang

❮ Previous
Next ❯

Citations

Sep 12, 2019·Cell Death & Disease·Neerajana DattaMrinal K Ghosh
Jul 2, 2019·Frontiers in Oncology·Isabel HeideggerRenate Pichler
Mar 2, 2021·Cancer Immunology, Immunotherapy : CII·Gennadi TulchinerMartin Thurnher

❮ Previous
Next ❯

Methods Mentioned

BETA
RNAseq
transfection
PCR
xenografts

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.